Navigation Links
National Patient Advocate Foundation Supports 340B Drug Discount Program Review Identifying Risks to Underinsured Patients

WASHINGTON, Feb. 13, 2013 /PRNewswire-USNewswire/ -- "As part of our mission to serve as the patient voice in improving access to, and reimbursement for, high-quality healthcare for millions of Americans, NPAF is proud to be part of important research related to the 340B Drug Discount Program, particularly in light of federal budgetary cuts in health care provider services.  Originally created by Congress in 1992 to help uninsured indigent patients gain better access to prescription medicines, the program requires pharmaceutical manufacturers to provide discounts on outpatient prescription drugs to entities that serve high numbers of uninsured indigent patients.

"More than 20 years after its creation, the 340B program appears to have strayed from its original purpose, leading to this recent analysis by our broad-based group of providers, pharmacists, patients and innovators. Among the potentially serious consequences highlighted in today's White Paper are concerns that some uninsured indigent patients may not be experiencing direct benefit from the program's existence; anecdotal evidence that clinical decision-making may be skewed by efforts to take advantage of the 340B discount; and growing evidence of displacement of non-340B providers who serve a key role in providing patient access to important health care services. Therefore, improved transparency and oversight of the 340B program is needed to ensure it remains aligned with its original intent.

"NPAF feels very strongly that this is a critical program today and going forward for the many patients who are uninsured and of indigent status. Because of the importance of the program, and due to our recent findings, we fully support and encourage a thorough examination of the 340B program by Congress to ensure it is meeting its original goals for the millions of Americans who depend upon it."

National Patient Advocate Foundation is a national non-profit organization providing the patient voice in improving access to, and reimbursement for, high-quality healthcare through regulatory and legislative reform at the state and federal levels. NPAF translates the experience of millions of patients who have been helped by our companion, Patient Advocate Foundation, which provides professional case management services to individuals facing barriers to healthcare access for chronic and disabling disease, medical debt crisis and employment-related issues at no cost. If you are in need of direct patient services, please contact Patient Advocate Foundation at 1-800-532-5274 or on the web at

SOURCE National Patient Advocate Foundation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Immunotech Laboratories Appoints New Chief Financial Advisor to Strengthen Companys Growth and International Expansion Plan
2. MGC Diagnostics Corporation Announces National Jewish Health Selects the Company as Preferred Provider for Cardiopulmonary Diagnostic Instrumentation
3. Prime Therapeutics named a 2013 National Top Workplace
4. Zacks Bull and Bear of the Day Highlights: Smithfield Foods, Logitech International, Sanofi, Isis Pharmaceuticals and Aegerion Pharmaceuticals
5. Rafarma Pharmaceuticals, Inc. Named 1 Of 4 National Strategic Pharmaceutical Suppliers To The Russian Federation
6. Novelos Therapeutics Presents Diapeutic Technology Platform At EMIT: Targeted Radiotherapy International Conference
7. PAREXEL International Reports Second Quarter Fiscal Year 2013 Results
8. Immunotech Laboratories Announces LOI With International Bio-Tech Partner For USA Clinical Trials Funding Of Patented HIV Medicines
9. NSF International Acquires the INASSA Group LLC, a Peruvian Leader in Analytical Testing, Certification, Inspection and Training for the Seafood/Fishing, Food and Pharmaceutical/Medical Industries
10. Life Technologies Establishes International Influenza Network
11. Tang Prize Foundation Established in Taiwan: Academia Sinica to be Responsible for the Nomination and Selection of the International Awards in Taiwan
Post Your Comments:
(Date:11/30/2015)... Nov. 30, 2015 (HK$,000)For the Six Months Ended 30 September 2015 2014RestatedChange%Turnover ... , 421,979 , 384,242 , ... , 34,719 , (18.3) Medical Insurance Administration ... , 16.1 Medical Devices and Accessories Sales , ... Chinese Herbal Medicines Sales , 2,822 , 2,917 ...
(Date:11/30/2015)... INDIANAPOLIS , Nov. 30, 2015  PTS Diagnostics, ... as CardioChek ® analyzers, A1CNow ® systems, ... of a family of patents that will propel the ... and Europe . The ... cameras, such as those on smartphones and tablets, and ...
(Date:11/30/2015)... , Nov. 30, 2015 Cumberland Pharmaceuticals (CPIX), today ... live at on December 3, 2015. TIME: ... TIME: 3:15p.m. ET LINK: --> ... --> ... where investors are invited to ask the company questions in ...
Breaking Medicine Technology:
(Date:11/30/2015)... (PRWEB) , ... November 30, 2015 , ... While powdered ... results in wasted time. Fortunately, an inventor from Chesterfield, Va., has found an easy ... to keep the scoop used to measure powdered contents in a canister or other ...
(Date:11/30/2015)... ... November 30, 2015 , ... In an interview with Andy Mitchell ... top ophthalmologist on Long Island’s east end. During the broadcast, entitled “Eyes: the Window ... treatment of glaucoma and cataracts, and how a visit with his grandmother to her ...
(Date:11/30/2015)... ... ... It’s inevitable that everyone will experience death in his or her lifetime. ... lives among us. It is your perspective, however, that determines how you view death ... T Sky understands that she may see death more frequently than most. As she ...
(Date:11/30/2015)... New York (PRWEB) , ... November 30, 2015 , ... ... Greater New York Dental Meeting. Their Ecosystem empowers dentists to make complex business decisions ... visit the booth will receive a free fee survey with 10 procedures customized by ...
(Date:11/30/2015)... (PRWEB) , ... November 30, 2015 , ... ... strategic alliance around Novus’ TIGR® Matrix Surgical Mesh technology for soft tissue repair ... polymers, TIGR® Matrix is a long-term resorbable surgical mesh intended to support and ...
Breaking Medicine News(10 mins):